MedNet Solutions attains record-setting corporate growth in 2015

NewsGuard 100/100 Score

MedNet Solutions, an innovative SaaS-based eClinical technology company that supports the entire spectrum of clinical research, is pleased to announce the attainment of record-setting corporate growth in 2015. MedNet's significant achievements are the result of the company's laser focus on (and growing international popularity of) iMedNet eClinical, it's comprehensive, easy-to-use and highly affordable cloud-based technology platform.

Key MedNet growth achievements in 2015 include:

  • Record overall sales of eClinical products and services
  • iMedNet eClinical sales growth of 98% (vs. 2014)
  • iMedNet eClinical backlog growth of 91% (vs. 2014)
  • Record R&D spending (46% increase vs. 2014)
  • Significant employee hiring growth (over 30%)
  • Inbound prospective customer inquiry growth of 40% (vs. 2014)

"2015 has clearly been a banner year for our company," noted M. Clareece West, Chief Operating Officer at MedNet Solutions. "Important reasons why MedNet has been able to grow so effectively include our continued focus on our existing clients' needs, our investment in 'operational owners' to insure ongoing client success, and our expanding suite of eClinical tools that make clinical trials more efficient for everyone involved."

"I'm thrilled that iMedNet is increasingly being selected as the 'eClinical solution of choice' to support research initiatives worldwide," remarked John M. (Rob) Robertson, President and CEO of MedNet Solutions. "And 2016 promises to be even more exciting as we roll out new features and capabilities that will further set iMedNet apart in the marketplace."

Source:

MedNet Solutions

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings